A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma

被引：0
|
作者：
Oladapo Yeku
Andrea L. Russo
Hang Lee
David Spriggs
机构：
[1] Harvard Medical School,Division of Hematology
[2] Massachusetts General Hospital,Oncology, Department of Medicine
[3] Harvard Medical School,Department of Radiation Oncology
[4] Massachusetts General Hospital,Biostatistics Center
[5] Harvard Medical School,undefined
[6] Massachusetts General Hospital,undefined
来源：
Journal of Translational Medicine | / 18卷
关键词：
Vulvar cancer; Pembrolizumab; Chemoradiation; Immunotherapy; Chemoimmunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study
    Tomono, Hiromi
    Taniguchi, Hirokazu
    Fukuda, Minoru
    Ikeda, Takaya
    Nagashima, Seiji
    Akagi, Kazumasa
    Ono, Sawana
    Umeyama, Yasuhiro
    Shimada, Midori
    Gyotoku, Hiroshi
    Takemoto, Shinnosuke
    Hisamatsu, Yasushi
    Morinaga, Ryotaro
    Tagawa, Ryuta
    Ogata, Ryosuke
    Dotsu, Yosuke
    Senju, Hiroaki
    Soda, Hiroshi
    Nakatomi, Katsumi
    Hayashi, Fumiko
    Sugasaki, Nanae
    Kinoshita, Akitoshi
    Mukae, Hiroshi
    THORACIC CANCER, 2023, 14 (28) : 2890 - 2894
  • [32] Phase II multi-site investigation of neoadjuvant pembrolizumab and adjuvant concurrent radiation and pembrolizumab with or without cisplatin in resected head and neck squamous cell carcinoma.
    Wise-Draper, Trisha Michel
    Old, Matthew O.
    Worden, Francis P.
    O'Brien, Paul E.
    Cohen, Ezra E. W.
    Dunlap, Neal
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study
    Xu, Tongpeng
    Bai, Jianan
    Zhao, Kun
    Chen, Xiaofeng
    Wang, Shuhui
    Zhu, Shusheng
    Sun, Chongqi
    Zhao, Chenhui
    Wang, Ting
    Zhu, Ling
    Hu, Meizhen
    Pang, Fei
    Zhang, Junling
    Wang, Wei
    Shu, Yongqian
    Li, Fang
    Zhou, Yue
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (13) : 9321 - 9331
  • [34] Phase II Study of Concurrent Chemo Irradiation with Weekly Cisplatin and Paclitaxel in the Treatment of Locally Advanced Squamous Cell Carcinoma of Cervix
    Varghese, S.
    Ram, T.
    Pavamani, S.
    Thomas, E.
    Jeyaseelan, V.
    Viswanathan, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S398 - S398
  • [35] Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279
    Horowitz, Neil S.
    Deng, Wei
    Peterson, Ivy
    Mannel, Robert S.
    Thompson, Spencer
    Lokich, Elizabeth
    Myers, Tashanna
    Hanjani, Parvis
    O'Malley, David M.
    Chung, Ki Young
    Miller, David S.
    Ueland, Frederick R.
    Dizon, Don S.
    Miller, Austin
    Mayadev, Jyoti S.
    Leath, Charles A.
    Monk, Bradley J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16) : 1914 - 1921
  • [36] Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck
    Echevarria, Michelle I.
    Yang, George Q.
    Chen, Dung-Tsa
    Kirtane, Kedar
    Russell, Jeffery
    Kish, Julie
    Muzaffar, Jameel
    Otto, Kristen
    Padhya, Tapan
    Mcmullen, Caitlin
    Patel, Krupal
    Chung, Christine H.
    Caudell, Jimmy J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : 341 - 347
  • [37] Chemoradiotherapy Combined with Nab-Paclitaxel plus Cisplatin in Patients with Locally Advanced Borderline Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase I/II Study
    Yu, N.
    Li, J.
    Chen, X.
    Wang, Z.
    Kang, X.
    Zhang, R.
    Qin, J.
    Zheng, Q.
    Feng, G.
    Deng, L.
    Zhang, T.
    Wang, W.
    Liu, W., Jr.
    Wang, J.
    Feng, Q.
    Lv, J.
    Chen, D.
    Zhou, Z.
    Xiao, Z.
    Li, Y.
    Bi, N.
    Li, Y.
    Wang, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E354 - E354
  • [38] Polymeric micellar paclitaxel plus cisplatin combined with tislelizumab as the first-line treatment of advanced unresectable esophageal squamous cell carcinoma: A phase II study.
    Cao, Guochun
    Li, Xiaoyou
    Liu, Delin
    Zhu, Jinghua
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation
    Fernando Munoz
    Pierfrancesco Franco
    Patrizia Ciammella
    Mario Clerico
    Mauro Giudici
    Andrea Riccardo Filippi
    Umberto Ricardi
    Radiation Oncology, 2
  • [40] Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation
    Munoz, Fernando
    Franco, Pierfrancesco
    Ciammella, Patrizia
    Clerico, Mario
    Giudici, Mauro
    Filippi, Andrea Riccardo
    Ricardi, Umberto
    RADIATION ONCOLOGY, 2007, 2 (1)
12345